Sofía Arias-Correal

Sofía Arias-Correal

Auto-generated profile, based on publicly available information

Sofía Arias-Correal

S. Arias-Correal, Universidad de La Sabana, Rheumatology, Chía, Colombia; Grupo de Estudio de las eSPondiloArtritis (GESPA); Hospital Militar Central, Bogotá DC, Colombia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2016 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
JMJesus Giovanny Ballesteros Muñoz
Jesus Giovanny Ballesteros Muñoz
RGRodrigo B. Giraldo
Rodrigo B. Giraldo
ASAna M. Santos
Ana M. Santos
JBJuan Manuel Bello-Gualteros
Juan Manuel Bello-Gualteros
JRJuan C. Rueda
Juan C. Rueda
JLJohn Londono
John Londono

6 May 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JLJohn Londono
John Londono
CPCésar Pacheco-Tena
César Pacheco-Tena
ASAna Maria Santos
Ana Maria Santos
MCMario Humberto Cardiel
Mario Humberto Cardiel
GRGustavo Rodríguez-Salas
Gustavo Rodríguez-Salas
RBRubén Burgos-Vargas
Rubén Burgos-Vargas
To compare the demographic, clinical, and laboratory characteristics, disease onset, and clinical features of radiographic axial Spondyloarthritis (r-axSpA) and non-radiographic axial Spondyloarthritis (nr-axSpA) patients. All patients who attended outpatient spondylarthritis (SpA) clinics at Hospital General de Mexico and the Instituto Nacional de la Nutrición from 1998 to 2005 and met the rheumatologist diagnostic criteria for SpA were selected. Then the SpA patients were classified by European Spondyloarthropathy Study Group criteria (ESSG). We selected SpA patients with axial presentation as axial SpA (axSpA), and they were classified as r-axSpA if they met modified New York (mNY) criteria for sacroiliitis and as nr-axSpA if they did not meet mNY criteria; to compared clinical, demographic, and laboratory test between the subgroups. It included 148 SpA patients; 55 (37.2%) patients had r-axSpA, and 70 (47.3%) had nr-axSpA. The nr-axSpA patients had a lower proportion of males (58.6% vs 78.2%, P < 0.05), lower HLA-B27 frequency (54.3%. vs. 92.7%, P < 0.05), were older at disease onset (21 vs 16 years; P < 0.01) and had a higher frequency of infections at disease onset (9.1% vs 32.9, P < 0.05) than r-axSpA. BASFI (2.9 vs 4.8; P < 0.0001), Dougados functional index (7 vs. 14; P < 0.05), and BASDAI (4.1 vs. 5.2; P < 0.001) were lower in patients with nr-axSpA than r-axSpA, respectively. The factors that most influenced the presentation of r-axSpA were history of uveitis (OR 14, 95% CI 2.3–85), HLA-B27 (OR 7.97, 95% CI, 2.96–122), male sex (OR 6.16, 95% CI, 1.47–25.7), axial enthesopathy count (OR 1.17 95% CI, 1.03–1.33). This study provides insight into the differences between nr-axSpA and r-axSpA in Mexico. Patients with r-axSpA were mainly male, with a younger presentation age, a higher prevalence of HLA-B27, more history of uveitis, fewer episodes of dactylitis, more axial enthesopathy, and higher disease activity than nr-axSpA.

1 September 2025 in The Journal of Rheumatology
Verified
Journal Article
Open access
PDF file
ICIgor Rueda Cárdenas
Igor Rueda Cárdenas
GRGustavo José Rodriguez
Gustavo José Rodriguez
ASAna María Santos
Ana María Santos
JDJuan Camilo Santacruz Devia
Juan Camilo Santacruz Devia
SASofía Arias-Correal
Sofía Arias-Correal
JLJohn Londono
John Londono
Objective: The Assessment of SpondyloArthritis international Society (ASAS) criteria classify spondyloarthritis (SpA) based on clinical presentation. Although widely applied, the measure’s performance in Colombia’s population remains unclear. This study aimed to characterize a Colombian SpA cohort, identify factors associated with peripheral SpA (pSpA), compare SpA subtypes, assess the performance of ASAS criteria, and compare the ASAS with modified New York (mNY) and European Spondyloarthropathy Study Group (ESSG) criteria. Methods: This cross-sectional study included patients with newly diagnosed SpA by ≥ 1 expert rheumatologist. Participants completed a structured survey, physical examination, imaging, and laboratory tests. Researchers classified patients using ASAS, ESSG, and mNY criteria and compared clinical characteristics across groups. Finally, the performance of the ASAS criteria relative to the rheumatologist’s diagnosis, mNY, and ESSG was analyzed. Results: The study analyzed 461 patients with SpA, of whom 58.1% had pSpA. Patients with axial SpA (axSpA) and pSpA differed significantly in age at onset, initial symptoms, buttock pain, Schober test, sacroiliitis, and HLA alleles. The ASAS criteria demonstrated a sensitivity of 90.8% when compared to rheumatologist diagnosis. Notably, 33.6% and 36.6% of patients classified as having radiographic axSpA (r-axSpA) by mNY or ESSG, respectively, were misclassified as pSpA under ASAS due to unmet entry criteria for axSpA. Conclusion: This large Colombian SpA cohort, predominantly comprising patients with pSpA, revealed distinct clinical and imaging features between axSpA and pSpA. The ASAS criteria showed high sensitivity but failed to classify a subset of patients with radiographic sacroiliitis as having r-axSpA, highlighting limitations in its entry criteria for axSpA.

3 August 2020 in Revista Colombiana de Nefrología
Verified
Journal Article
Open access
PDF file
JAJosé Arias
José Arias
SASofía Arias
Sofía Arias
MMMariana Michelsen
Mariana Michelsen
SOSebastián Orozco
Sebastián Orozco
CPCatalina Pabón
Catalina Pabón
AVAna Villate
Ana Villate
En Colombia el consumo de sustancias ilícitas incrementa a diario. Este aumento del consumo en la población involucra tanto a jóvenes menores de 16 años como a adultos jóvenes. Por lo anterior, se presentan complicaciones asociadas al consumo de estas sustancias que de otra manera, serían inusuales de encontrar en este grupo poblacional. En este reporte de caso, se revisará como el uso de cocaína llevo a un paciente joven al desarrollo de daño renal agudo con requerimiento de terapia de reemplazo renal, que en sus hallazgos histológicos puede corresponder a una glomerulonefritis rápidamente progresiva, o a enfermedad tubulointersticial: necrosis tubular aguda (NTA) o nefritis intersticial aguda (NIA). Palabras clave: Drogas ilícitas, Falla renal aguda, Necrosis tubular aguda.

2 January 2024 in Revista Colombiana de Endocrinología, Diabetes & Metabolismo
Verified
Journal Article
Open access
PDF file
PJPaula Andrea Chacón Jaramillo
Paula Andrea Chacón Jaramillo
DODaniel Osorio
Daniel Osorio
SASofía Arias-Correal
Sofía Arias-Correal
MÁMauricio Álvarez
Mauricio Álvarez
MCManuel Cabrera
Manuel Cabrera
IGIsaac Guzmán
Isaac Guzmán
Introducción: los tumores de ovario productores de andrógenos corresponden al 0,1-0,8?% de las causas de hiperandrogenismo clínico en mujeres. Los tumores de células de Leydig representan entre el 5?% y el 8?% de los tumores de ovario, que generalmente son benignos y unilaterales; entre el 7?% y el 18?% presentan como síntoma principal hirsutismo y son causa de hiperandrogenismo y virilización en mujeres posmenopáusicas. Objetivo: presentar un caso de virilización femenina secundario a tumor de células de Leydig del ovario; guiar al lector a través de la discusión de las deferentes etiologías de hiperandrogenismo en mujeres posmenopáusicas y resumir en un algoritmo el abordaje diagnóstico de pacientes con hiperandrogenismo. Presentación del caso: se presenta el caso de una mujer posmenopáusica con cuadro de hirsutismo y alopecia androgénica de un año de evolución, niveles de testosterona marcadamente elevados y resonancia nuclear magnética (RNM) pélvica que reporta una masa en la región anexial derecha. Es llevada a salpingooforectomía bilateral con reporte de tumor maligno de células de Leydig, estadio IA. Posterior a la resección se resuelve el hiperandrogenismo bioquímico y mejoran el hirsutismo y la alopecia. Discusión: se discute la manera de abordar a las pacientes posmenopaúsicas con evidencia de hiperandrogenismo según el algoritmo creado. Conclusión: es importante realizar una investigación meticulosa de los posibles diagnósticos diferenciales, al tener en cuenta que los signos de hiperandrogenismo de rápida instauración deben alertar sobre la posibilidad de una neoplasia productora de andrógenos.